MENU
BTAI
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
BioXcel Therapeutics (BTAI) Ownership - Who owns BioXcel Therapeutics?
Industry: @Biotechnology
Profile
Industry
Biotechnology
Address
555 Long Wharf Drive
Phone
+1 475 238-6837
Employees
74
Web
https://www.bioxceltherapeutics.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
18.86M
P/E Ratio
N/A
Total Cash
40.39M
Projected Growth
N/A
Total Debt
104.97M
Revenue
2.28M
Risk (Beta)
0.29
Dividend Yield
N/A
Total Cash/Share
0.84
Total Debt/Equity
N/A
Revenue/Share
0.06 USD as % of share price
Fundamentals
BTAI
Capitalization
18.9M
P/E Ratio
N/A
Risk (Beta)
0.29
Dividend Yield
N/A
Total Cash
40.4M
Total Cash/Share
0.84
Total Debt
105M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.06%
Revenue
2.28M
ROE
N/A
Book Value
-85.63M
P/B Ratio
N/A
Cash Flow
N/A
Earnings
-2.04
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
42K
Current Ratio
1.87
Current Revenue Per Employee
2891.89
Dividends Per Share - Security
N/A
EBITDA
-56.15M
Float
N/A
Float - Current
N/A
Gross Income Margin
-446.73
Revenue To Assets
-95.08
Shares Held By Institutions
9.91M
Shares Outstanding - Current
48.3M
Total Liabilities
135M
Total Volume MTD
N/A
Value
-1
Gain YTD
-86.776
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a biopharmaceutical company
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
555 Long Wharf Drive
Phone
+1 475 238-6837
Employees
74
Web
https://www.bioxceltherapeutics.com